Our News on Newswise

Newswise: 65c267e49b9a2_Screenshot2024-02-06115629.png

Immune networks in tumors prime responses to a personalized immunotherapy

Through an analysis of tumor samples collected over time from patients with advanced melanoma, a Ludwig Cancer Research study has identified a set of preexisting conditions in tumors that predict whether such patients are likely to respond to a...
6-Feb-2024 11:05 AM EST Add to Favorites

Newswise: 65b7f031f1cff_Screenshot2024-01-29133605.png

Immunologist Lydia Lynch appointed member of Ludwig Princeton

It is with great pleasure that we announce the appointment of Lydia Lynch as a full member of the Princeton Branch of the Ludwig Institute for Cancer Research.
29-Jan-2024 1:05 PM EST Add to Favorites

Newswise: 65a95dceeaf75_Screenshot2024-01-18114300.png

Analysis of brain tumor blood vessels yields a candidate therapy—and a platform to find more

A Ludwig Cancer Research study has generated a granular portrait of how the cellular and molecular components of the blood vessels that feed brain metastases of melanoma and lung and breast cancers differ from those of healthy brain tissue,...
18-Jan-2024 12:05 PM EST Add to Favorites

Newswise: 652ed4a1b40c0_ChiVanDang.png

Ludwig Cancer Research launches Leadership Fellows Program

Ludwig Cancer Research announces its launch of the Ludwig Leadership Fellows Program, which aims to accelerate the careers of exceptional young scientists by helping them establish genuinely independent programs of research immediately after the...
17-Oct-2023 2:25 PM EDT Add to Favorites

Newswise: 65147c23362aa_JohannaJoyce.png

Study shows how brain tumors make certain immune cells turn traitor

A Ludwig Cancer Research study has for the first time exhaustively analyzed neutrophils that reside in brain tumors, detailing how the immune cells support brain cancer survival and how they’re turned by the tumor microenvironment into enablers of...
27-Sep-2023 2:05 PM EDT Add to Favorites

Newswise: 650c648c19bd4_SaraBobisse.png

Combination of cancer vaccine and T cell therapy benefits patients with advanced ovarian cancer

A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with...
21-Sep-2023 11:05 AM EDT Add to Favorites

Newswise: 650b0c8c402cc_PhotoAJ.jpg

Disrupting A Core Metabolic Process In T Cells May Improve Their Therapeutic Efficacy

In exploring an aspect of how killer T cells generate the raw materials required for their proliferation, a Ludwig Cancer Research study has uncovered an unexpected link between the immune cells’ metabolism, regulation of gene expression,...
20-Sep-2023 11:00 AM EDT Add to Favorites

Newswise: 64cbf4526c5d0_MikaelPittet.png

Scientists uncover a startling—and exploitable—coordination of gene expression in tumors

A Ludwig Cancer Research study has identified a pair of genes whose expression by a type of immune cell within tumors is predictive of outcomes for cancer patients and is linked to a vast network of gene expression programs, engaged by multiple cell...
3-Aug-2023 2:05 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Our experts are coming soon...

About

Ludwig Cancer Research is an international collaborative network of acclaimed scientists that has pioneered cancer discoveries for more than 40 years. Ludwig combines basic research with the ability to translate its discoveries and conduct clinical trials to accelerate the development of new cancer diagnostics and therapies. Since 1971, Ludwig has invested more than $2.5 billion in life-changing cancer research through the not-for-profit Ludwig Institute for Cancer Research and the six U.S.-based Ludwig Centers.

Experts

Contacts

Unmesh Kher
Editorial Director
Cancer research

ukher@lcr.org

Our Multimedia on Newswise

Twitter

close
0.26014